University researchers in Greece studying acupuncture for musculoskeletal pain of a chronic nature, have shown pain intensity, disability and salivary cortisol levels, can all be reduced. Thirty patients were randomly assigned to receive either physiotherapy, acupuncture, or sham ultrasound therapy for ten sessions.
Acupuncture was associated with greater decreases in pain intensity and disability than either physiotherapy or sham ultrasound. Significant decreases in salivary cortisol levels were observed in all three groups.
(The effect of treatment regimens on salivary cortisol levels in patients with chronic musculoskeletal disorders. Journal of Bodywork & Movement Therapies, January 2020.)
An American study shows acupuncture reduces pain after bone marrow transplantation, and decreases postoperative opioid use. Sixty adults with multiple myeloma and undergoing chemotherapy and stem cell transplantation, were randomised to receive either true or sham acupuncture once daily for five days. The first treatment was given the day after chemotherapy. Opioid use was assessed at 5, 15 and 30 days after transplantation.
All 15 true acupuncture patients who were non-users of opioids, remained free of them still at the end of the study. By contrast, 20% of those given sham acupuncture started using opioids after chemotherapy and stem cell infusion (day 5), and by the 30 day point, 40% were users. As regards patients who were already opioid users at baseline, by day 30, 21% in the true acupuncture group and 30% in the sham acupuncture group, had increased their use. The researchers conclude that acupuncture appears to significantly reduce the need for pain medications during this procedure and warrants further studies as an opioid-sparing intervention.
(Reduction of Opioid Use by Acupuncture in Patients Undergoing Hematopoietic Stem Cell Transplantation: Secondary Analysis of a Randomized, Sham-Controlled Trial. Pain Medicine, 9 September 2019.)
American researchers have shown electroacupuncture significantly reduces pain after kidney stone removal by percutaneous nephrolithotomy. They randomised 51 patients to receive either electroacupuncture, sham electroacupuncture or no acupuncture. Flank and abdomen pain was lower at all time points in the electroacupuncture group compared with the other two groups. Immediate post-operative opioid use was also lower in the electroacupuncture group, with two patients not requiring any opioids.
The researchers say that electroacupuncture significantly reduces pain and opioid usage without any adverse effects, and this promising treatment warrants further investigation.
(A Randomized, Double-Blind, Sham-Controlled Study Assessing Electroacupuncture for the Management of Postoperative Pain after Percutaneous Nephrolithotomy. Journal of Endourology, March 2019.)
Authors of a large American pilot study have concluded acupuncture is a feasible and beneficial, non-pharmacological option for treating pain in the emergency department. The researchers’ aim was to determine the feasibility of employing an acupuncturist in an urban emergency department, to provide an acute pain management option.
Of 706 patients with acute pain, 379 agreed to try acupuncture in the emergency department of a Milwaukee hospital. Their mean pain scores decreased significantly (from 6.5 to 3.4), as did their levels of stress, anxiety and nausea. The treatment was well received.
One author reported, “We believe this research is very important because America is currently in the throes of a pain management and opioid crisis. What contributed to this crisis was a belief that new technologies, surgical procedures, and the liberal use of opioids would be the answers to controlling human pain. As we now know, these strategies have not proven efficacious in mitigating pain, suffering, and disability to the extent the public was led to believe.”
(ED Acupuncture: Feasibility, Acceptability, and Impact on Pain. American Pain Society Annual Meeting, April 2019.)
Research commissioned by the US State of Vermont shows that acupuncture is effective for chronic pain and offers a wide array of other benefits, for patients on low incomes and treated under the government-funded Medicaid scheme. Previous studies have shown that this population is hampered in its access to non-pharmacological treatments, by lack of health insurance. In a pragmatic randomised trial, Medicaid patients with chronic pain were offered up to 12 acupuncture sessions over a 60 day period. This resulted in 156 patients (111 women & 45 men) receiving an average 8.2 treatments.
– There were significant improvements in pain intensity, pain interference, physical function, fatigue, anxiety, depression, sleep and social isolation.
– 57% of patients using non-opioid analgesics reported reductions in use.
– 32% of patients using opioid analgesics reported reductions in use.
– 74% of employed patients reported improved capacity to work.
– 96% of patients would recommend acupuncture to others with chronic pain.
(Acupuncture for Chronic Pain in the Vermont Medicaid Population: A Prospective, Pragmatic Intervention Trial. Global Advances in Health & Medicine, April 2018.)